Φορτώνει......
The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease
BACKGROUND: Recent publications have reported follow-up of the RTS,S/AS01 malaria vaccine candidate Phase III trials at 11 African sites for 32 months (or longer). This includes site- and time-specific estimates of incidence and efficacy against clinical disease with four different vaccination sched...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Malar J |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634589/ https://ncbi.nlm.nih.gov/pubmed/26537608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0969-8 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|